3.61
4.18%
0.145
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Titan Pharmaceuticals Inc De Azioni (TTNP) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
Revenues |
-
|
- | 0.004 | 0.083 | 0.098 |
Operating Expenses |
30.30%
1.063
|
1.525 | 2.471 | 1.671 | 1.795 |
Operating Income/Loss |
30.30%
-1.063
|
-1.525 | -2.467 | -1.588 | -1.697 |
Nonoperating Income/Loss |
107.69%
0.003
|
-0.039 | 1.723 | 0.002 | 0.022 |
Income/Loss From Continuing Operations Before Tax |
125.30%
-1.06
|
4.189 | -0.744 | -1.586 | -1.675 |
Income/Loss From Continuing Operations After Tax |
32.23%
-1.06
|
-1.564 | -0.744 | -1.586 | -1.675 |
Net Income/Loss
|
32.23%
-1.06
|
-1.564 | -0.744 | -1.586 | -1.675 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
100.00%
-
|
8.01 | - | - | - |
Basic Average Shares |
105.98%
0.853
|
-14.26 | 15.02 | 15.02 | - |
Diluted Average Shares |
105.98%
0.853
|
-14.26 | 15.02 | 15.02 | 15.02 |
Basic Earnings Per Share |
82.63%
-1.24
|
-7.14 | -0.05 | -0.11 | -0.11 |
Diluted Earnings Per Share |
82.63%
-1.24
|
-7.14 | -0.05 | -0.11 | -0.11 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):